Prediction of absolute risk reduction of cardiovascular events with perindopril for individual patients with stable coronary artery disease - results from EUROPA. [electronic resource]
Producer: 20160105Description: 194-9 p. digitalISSN:- 1874-1754
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Clinical Decision-Making -- methods
- Coronary Artery Disease -- drug therapy
- Death, Sudden, Cardiac -- epidemiology
- Dose-Response Relationship, Drug
- Double-Blind Method
- Europe -- epidemiology
- Female
- Follow-Up Studies
- Humans
- Incidence
- Male
- Middle Aged
- Perindopril -- administration & dosage
- Precision Medicine -- methods
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.